The genetics of obesity

Current Opinion in Genetics and Development

Volumn 7, Issue 3, 1997, Pages

  Naggert, Jürgen ^a   Harris, Tim ^b   North, Michael ^b  

^a JACKSON LABORATORY   (United States)

^b CELERA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ANIMAL GENETICS; ANIMAL MODEL; APPETITE; BODY WEIGHT; GENE MUTATION; GENETICS; HERITABILITY; LIPID METABOLISM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW;

ANIMALIA;

EID: 0343471934     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80155-4     Document Type: Article

References (60)

1. Harris RBS: Role of set point theory in regulation of body weight. FASEB J 1990, 4:3310-3318. [See also correspondence FASEB J 1991, 5:2105-2106 and FASEB J 1992, 6:794.]
2. Harris RBS: Role of set point theory in regulation of body weight. FASEB J 1990, 4:3310-3318. [See also correspondence FASEB J 1991, 5:2105-2106 and FASEB J 1992, 6:794.]
3. Harris RBS: Role of set point theory in regulation of body weight. FASEB J 1990, 4:3310-3318. [See also correspondence FASEB J 1991, 5:2105-2106 and FASEB J 1992, 6:794.]
4. Wadden TA: Treatment of obesity by moderate and severe caloric restriction: results of a clinical research trial. Ann Intern Med 1993, 119:688-693.
5. Fairburn CG, Cooper Z: New perspectives on dietary behavioural treatments for obesity. Int J Obes Relat Metab Disord 1996, 20:S9-S13.
6. Bray GA, Fisler J, York DA: Neuroendocrine control of the development of obesity: understanding gained from studies of experimental animal models. Front Neuroendocrinol 1990, 11:128-181.
7. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989, 149:1514-1520.
8. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE: The body-mass index of twins who have been reared apart. New Engl J Med 1990, 322:1483-1487.
9. Carmelli D, Cardon LR, Fabsitz R: Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments? Am J Hum Genet 1994, 55:566-573.
10. Daniels SE, Bhattacharyya S, James A, Leaves NI, Young A, Hill MH, Faux JA, Ryan GF, Le Souef PN, Lathrop GM, Musk AW, Cookson WOCM: A genome wide search for quantitative trait loci underlying asthma. Nature 1996, 383:247-250. This work, along with [9], demonstrates the feasibility of genome scans in dissecting the genetics of traits with many confounding genetic and environmental influences, suggesting that the same approach may be used to localise human obesity genes.
11. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM et al.: A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994, 371:130-136.
12. •].
13. •].
14. •] are illustrative of the difficulty in identifying mutations in complex traits such as human obesity. They show that linkage may be observed without obvious coding region sequence variation between affected and unaffected individuals (in the case of the OB gene). Even when sequence variation is established between probands and controls, the functional implications may be unclear (as in the case of the adrenergic receptor).
15. Kwitek-Black AE, Carmi R, Duyk GM, Buetow KH, Elbedour K, Parvari R, Yandava CN, Stone EM, Sheffield VC: Linkage of Bardet-Biedl syndrome to chromosome 16q and evidence for non-allelic genetic heterogeneity. Nat Genet 1993, 5:392-396.
16. Collin GB, Marshall JD, Cardon LR, Nishina PM: Homozygosity mapping of Alström syndrome to chromosome 2p. Hum Mol Genet 1997, 6:213-220.
17. Coleman DL: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978, 14:141-148.
18. Smith CK, Romsos DR: Cold acclimation of obese (ob/ob) mice: effects on onskeletal muscle and bone. Metabolism 1984, 33:858-863.
19. Coleman DL: Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973, 9:294-298.
20. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
21. •].
22. •].
23. •] provide the widely publicized reports of the startling weight losses produced by leptin administration to obese mice. Clinical trials which hope to stimulate equivalent weight loss in obese humans are now in progress.
24. •].
25. ••] highlight an important feature of leptin action which has only come to light recently: that it can powerfully suppress an adaptation to starvation in fasted animals. These reports raise the possibility that the leptin pathway evolved to provide resistance to starvation rather than a mechanism of limiting food intake in a plentiful environment.
26. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995, 1:1311-1314.
27. Hamilton BS, Paglia D, Kwan AY, Deitel M: Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med 1995, 1:953-956.
28. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S et al.: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight reduced subjects. Nat Med 1995, 1:1155-1161. This report provides a comprehensive analysis of leptin levels in obese humans and rodents. It establishes that very few humans have disproportionately low levels of serum leptin. A resistance to leptin is therefore likely to be a common cause of human obesity, with the caveat being that leptin may be solely a signal for starvation, not satiety.
29. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr: Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996, 2:589-593.
30. Madej T, Boguski MS, Bryant SH: Threading analysis suggests that the obese gene product may be a helical cytokine. FEBS Lett 1995, 373:13-18.
31. ••].
32. ••].
33. ••].
34. ••] describe the characterization and mutational analysis of the hypothalamic leptin receptor. From the isolation of the leptin gene, progress in characterizing its receptor has been exceptionally rapid. These reports describe important features of its regulation and cytokine-like signaling ability within the satiety center.
35. Cohen B, Novick D, Rubinstein M: Modulation of insulin activities by leptin. Science 1996, 274:1185-1188.
36. Emilsson V, Liu Y-L, Cawthorne MA, Morton NM, Davenport M: Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997, 46:313-316.
37. •].
38. Levine AS, Morley JE: Neuropeptide Y: a potent inducer of consummatory behaviour in rats. Peptides 1984, 5:1025-1029.
39. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL et al.: A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996, 382:168-171.
40. •].
41. •], highlights the complexity which may exist in hypothalamic bodyweight signaling and the difficulties in interpreting the significance of individual components of that response. NPY levels clearly signal leptin absence and are necessary for the hyperphagic response, yet NPY may not be important for normal bodyweight regulation.
42. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R, Maratos-Flier E: A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 1996, 380:243-247.
43. vy/- mice: ectopic expression of the agouti gene. FASEB J 1994, 8:479-488.
44. Bultman SJ, Michaud EJ, Woychik RP: Molecular characterization of the mouse agouti locus. Cell 1992, 71:1195-1204.
45. Kwon HY, Bultman SJ, Loffler C, Chen WJ, Furdon PJ, Powell JG, Usala AL, Wilkison W, Hansmann I, Woychik RP: Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc Natl Acad Sci USA 1994, 91:9760-9764.
46. Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO: Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 1994, 371:799-802.
47. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD: Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994, 8:1298-1308.
48. ••].
49. ••] firmly establishes the hypothalamic melanocortin 4 receptor as a key regulator of bodyweight and the stimulation of melanocortinergic neurons as a method of fat mass regulation.
50. Coleman DL, Eicher EM: Fat (fat) and tubby (tub): two autosomal recessive mutations causing obesity syndromes in the mouse. J Hered 1990, 88:424-427.
51. •].
52. Cool DR, Normant E, Shen F, Chen H, Pannell L, Zhang Y, Loh YP: Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpe/fat mice. Cell 1997, 88:73-83.
53. Rovere C, Viale A, Nahon J, Kitabgi P: Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice. Endocrinology 1996, 137:2954-2958.
54. Heckenlively JR, Chang B, Erway LC, Peng C, Hawes NL, Hageman GS, Roderick TH: Mouse model for Usher syndrome: linkage mapping suggests homology to Usher type I reported at human chromosome 11p15. Proc Natl Acad Sci USA 1995, 92:11100-11104.
55. •].
56. •] provide information about the molecular mechanisms which can lead to a late-onset obesity, rather than the severe early onset obesity observed in obese and diabetes mice. Late-onset obesity is prevalent among human populations and these models may therefore highlight novel and clinically important pathways.
57. Flier JS, Cook KS, Usher P, Spiegelman BM: Severely impaired adipsin expression in genetic and acquired obesity. Science 1987, 237:405-408.
58. Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS: Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993, 366: 740-742.
59. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 1995, 83:813-819. This report describes the characterization of a key regulator of adipocyte differentiation - a process required for lipid accumulation as fat tissue and for leptin secretion into the circulation.
60. Spiegelman BM, Flier JS: Adipogenesis and obesity: rounding out the big picture. Cell 1996, 87:377-389.